Standard InChI: InChI=1S/C30H34N8O3/c1-5-28(39)32-23-17-24(26(40-4)18-25(23)37-13-15-41-16-14-37)33-30-31-12-11-27(34-30)38-20-22(19-36(2)3)29(35-38)21-9-7-6-8-10-21/h5-12,17-18,20H,1,13-16,19H2,2-4H3,(H,32,39)(H,31,33,34) (Source: PubChem)
IUPAC Name: N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenylpyrazol-1-yl]pyrimidin-2-yl]amino]-4-methoxy-2-morpholin-4-ylphenyl]prop-2-enamide (Source: PubChem)
PubChem CID: 121269225 (Source: PubChem)
SMILES String: CN(C)CC1=CN(N=C1C2=CC=CC=C2)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N5CCOCC5)OC (Source: PubChem)
Connectivity SMILES string: CN(C)CC1=CN(N=C1C2=CC=CC=C2)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N5CCOCC5)OC (Source: PubChem)
Standard InChIKey: RRMJMHOQSALEJJ-UHFFFAOYSA-N (Source: PubChem)
CAS Registry Number: 1903008-80-9 (Source: PubChem)
ChEMBL ID: CHEMBL4558324 (Source: PubChem)
CompTox Dashboard Substance ID: DTXSID601376595 (Source: PubChem)
WHO ATC Classification Drug Code: L01EB09 (Source: ChEMBL)
WHO ATC Classification Drug Name: Lazertinib (Source: ChEMBL)
Connectivity SMILES string: C=CC(=O)Nc1cc(Nc2nccc(-n3cc(CN(C)C)c(-c4ccccc4)n3)n2)c(OC)cc1N1CCOCC1 (Source: ChEMBL)
International Nonproprietary Name: Lazertinib (Source: ChEMBL)
Preferred Name: LAZERTINIB (Source: ChEMBL)
Standard InChI: InChI=1S/C30H34N8O3/c1-5-28(39)32-23-17-24(26(40-4)18-25(23)37-13-15-41-16-14-37)33-30-31-12-11-27(34-30)38-20-22(19-36(2)3)29(35-38)21-9-7-6-8-10-21/h5-12,17-18,20H,1,13-16,19H2,2-4H3,(H,32,39)(H,31,33,34) (Source: ChEMBL)
Standard InChIKey: RRMJMHOQSALEJJ-UHFFFAOYSA-N (Source: ChEMBL)
US Adopted Name: Lazertinib (Source: ChEMBL)